✓ Betaling met creditcard hersteld — veilige afrekening via Privacy Shield

Aprecap

Aprecap (Aprepitant 125/80 mg) — Cipla NK1 receptor antagonist antiemetic for prevention of acute and delayed chemotherapy-induced nausea/vomiting.

Medisch beoordeeld door Morgan Ellis — Apotheekonderzoeker · 8 jaar ervaring  · Laatst beoordeeld: mei 2026

Versleutelde checkout
Crypto betaalt 10% minder
Discrete wereldwijde levering
1.400+ klanten · 50+ landen

Dit product is momenteel niet op voorraad en niet beschikbaar.

Snelle antwoord

Aprecap — Aprepitant 125 mg/80 mg (Cipla Inc). NK1 receptor antagonist antiemetic for prevention of acute and delayed nausea/vomiting from highly and moderately emetogenic chemotherapy (cisplatin, AC, MEC). Used in combination with 5-HT3 antagonist + dexamethasone.

Wat u krijgt bij MedsBase:

  • WHO-GMP gecertificeerde fabrikant
  • Discrete verpakking in een gewone envelop
  • Wereldwijde verzending
  • Beoordeeld door 1.400+ klanten (lees beoordelingen)

📦 Reshipment Assurance: als uw bestelling niet is aangekomen binnen 20 werkdagen na verzending, sturen wij het opnieuw zonder extra kosten. Lees het beleid.

Waarom bestellen bij MedsBase

Aprecap ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.

CYP3A4 interactions
Aprepitant is a moderate CYP3A4 inhibitor. Significant interactions with dexamethasone (raises levels — dose-reduce dexamethasone 50%), warfarin (transient INR fall), oral contraceptives (efficacy reduced — use additional non-hormonal method during therapy and for 1 month after).

Veelgestelde vragen

When is this used?

NK1 receptor antagonist antiemetic for prevention of acute and delayed nausea/vomiting from highly and moderately emetogenic chemotherapy (cisplatin, AC, MEC). Used in combination with 5-HT3 antagonist + dexamethasone.

Bijwerkingen?

Class-specific — see safety boxes above. Most supportive cancer medications are well-tolerated when used per protocol but require specialist supervision.

Geneesmiddelinteracties?

Always disclose all medications. Cancer supportive therapy interacts with multiple cytotoxics, chemo regimens, and concomitant medications.

Zwangerschap?

Variable by molecule. Consult oncology for pregnancy planning during cancer therapy.

Monitoring?

Specialist-determined — typically FBC, electrolytes, renal/liver function, cardiac monitoring as relevant.

Wat als ik een dosis vergeet?

Take when you remember; do not double up. Discuss with oncology team if multiple doses missed.

When is treatment finished?

Determined by clinical response, planned regimen length, and patient tolerance.

Opslag?

Per package insert — typically below 25-30°C, away from light and moisture. Pregnant household members should not handle broken tablets/capsules.

Cost?

Generic Indian biosimilars and chemical equivalents are dramatically less expensive than originator products with documented bioequivalence and clinical equivalence.

Vaccines?

Coordinate with oncology — live vaccines may be contraindicated during cancer therapy.

Other Cancer & Supportive Medications

  • Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
  • Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
  • Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
  • Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
  • Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
Medische disclaimer: Cancer therapy is highly individualised. Specific drug, dose, schedule, monitoring, and supportive care must be determined by a qualified oncologist or haematologist based on tumour biology, staging, comorbidities, and goals of care. This information is educational; it does not substitute for professional medical advice.

More options in Anti Cancer Medication

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Sterkte

125 mg

Hoeveelheid

3 Capsule/s, 6 Capsule/s, 9 Capsule/s

Farmaceutische vorm

Tablet/s

Fabrikant

Glenmark Pharmaceuticals

Behandeling

Nausea and vomiting due to chemotherapy

Generiek merk

Aprepitant

Beoordelingen

Er zijn nog geen beoordelingen

Plaats een beoordeling
Aprecap Aprecap
Beoordeling*
0/5
* Beoordeling is verplicht
* Antwoord is verplicht
Jouw beoordeling
* Beoordeling is verplicht
Naam
* Naam is verplicht
Voeg foto's of video toe aan je beoordeling

Vragen & antwoorden

Stel een vraag
Aprecap Aprecap
Uw vraag
* Vraag is verplicht
Naam
* Naam is verplicht
Er zijn nog geen vragen